AMZN
Amazon.com, Inc.
AMZN has the edge over OPLN overall, supported by stronger valuation and stronger modeled upside.
OPLN
OPENLANE, Inc.
OPLN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
OPLN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Healthy |
OPLN's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
OPLN PE Valuation
OPLN has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over OPLN on the outlook, with more favorable profitability expectations.
OPLN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPLN, with profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over OPLN on earnings quality, reporting a profit while its opponent remains loss making.
OPLN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | — |
| Q3 2026 | -$0.74 | -185% |
| Q2 2026 | -$0.85 | -215% |
| Q4 2021 | $0.12 | +$0.35 |
| Q3 2021 | -$0.05 | -136% |
| Q2 2021 | $0.28 | +56% |
| Q1 2021 | $0.00 | -100% |
| Q4 2020 | -$0.23 | -122% |
OPLN has swung to a loss: it lost $0.74 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over OPLN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over OPLN on profitability, with a higher operating margin.
OPLN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $561.2M | +13% |
| Q2 2026 | $554.6M | +15% |
| Q1 2026 | $527.9M | +15% |
| Q4 2025 | $494.3M | +8.6% |
| Q3 2025 | $498.4M | +11% |
| Q2 2025 | $481.7M | +12% |
| Q1 2025 | $460.1M | +11% |
| Q4 2024 | $455M | +16% |
OPLN's revenue has grown year over year for 10 quarters in a row: $561M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.5 points |
| Q2 2026 | 12% | +2.3 points |
| Q1 2026 | 14% | +2.7 points |
| Q4 2025 | 8.6% | -8.8 points |
| Q3 2025 | 11% | -5.3 points |
| Q2 2025 | 9.8% | -3.1 points |
| Q1 2025 | 11% | -5.4 points |
| Q4 2024 | 17% | +2.7 points |
OPLN's operating margin was 13% last quarter, up 1.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
OPLN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $83.3M | +45% |
| Q2 2026 | $39M | -32% |
| Q1 2026 | $146.5M | +32% |
| Q4 2025 | $110.8M | +493% |
| Q3 2025 | $57.6M | -47% |
| Q2 2025 | $57.4M | +134% |
| Q1 2025 | $110.7M | +27% |
| Q4 2024 | $18.7M | +117% |
OPLN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over OPLN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
OPLN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7% | +8.2M shares |
| 1 year | +16% | +17.1M shares |
| 3 years | +7.8% | +9.1M shares |
| 5 years | -3% | -3.9M shares |
| Available history | -5.6% | -7.5M shares |
OPLN has 125M diluted shares, up 16% from a year ago, despite $101M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $43.3M |
| Q2 2026 | $22.5M |
| Q1 2026 | $25.7M |
| Q4 2025 | $9.8M |
| Q3 2025 | $26.4M |
| Q2 2025 | $9.3M |
| Q1 2025 | $100,000 |
| Q4 2024 | — |
OPLN spent $101M buying back its own shares over the past year, up 183% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over OPLN on leverage, with a lower net debt burden relative to earnings.
OPLN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | 0.2x | Very low |
OPLN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
OPLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.6 | Neutral |
| Stochastic | 32.5 | Neutral |
OPLN's weekly RSI is 48 (neutral) and its Stochastic is 33 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
OPLN PE vs Consumer Cyclical Sector
| Metric | OPLN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OPLN has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over OPLN on trend strength, trading above more of its moving averages.
OPLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 4.1% below |
| 20 week MA | $36.7 | 5.4% below |
| 50 week MA | $33.6 | 3.3% above |
| 100 week MA | $28.5 | 22% above |
| 200 week MA | $22.2 | 57% above |
OPLN has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over OPLN on returns for 2026, with the stronger performance.
OPLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.6 | $18.2 | -16% |
| 2021 | $18.2 | $15.5 | -15% |
| 2022 | $15.5 | $12.8 | -18% |
| 2023 | $12.8 | $14.8 | +16% |
| 2024 | $14.8 | $20.1 | +36% |
| 2025 | $20.1 | $31.0 | +54% |
| 2026 YTD | $31.0 | $34.7 | +12% |
OPLN has finished lower in three of the last six years. It's up 12% so far in 2026.